AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD)

NCT00240331 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2776

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Failure

Interventions

DRUG: 10mg Rosuvastatin
DRUG: Placebo

Sponsor

AstraZeneca